The estimated Net Worth of Vu Truong is at least $568 Тысяча dollars as of 24 June 2024. Dr Truong owns over 714,286 units of Aridis Pharmaceuticals Inc stock worth over $1,379 and over the last 6 years he sold ARDS stock worth over $0. In addition, he makes $566,125 as Founder и CEO & Director at Aridis Pharmaceuticals Inc.
Dr has made over 3 trades of the Aridis Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 714,286 units of ARDS stock worth $50,000 on 24 June 2024.
The largest trade he's ever made was buying 714,286 units of Aridis Pharmaceuticals Inc stock on 24 June 2024 worth over $50,000. On average, Dr trades about 81,587 units every 118 days since 2019. As of 24 June 2024 he still owns at least 1,378,639 units of Aridis Pharmaceuticals Inc stock.
You can see the complete history of Dr Truong stock trades at the bottom of the page.
Dr. Vu L. Truong is the Founder, CEO & Director at Aridis Pharmaceuticals Inc.
As the Founder и CEO & Director of Aridis Pharmaceuticals Inc, the total compensation of Dr Truong at Aridis Pharmaceuticals Inc is $566,125. There are no executives at Aridis Pharmaceuticals Inc getting paid more.
Dr Truong is 57, he's been the Founder и CEO & Director of Aridis Pharmaceuticals Inc since . There are 5 older and no younger executives at Aridis Pharmaceuticals Inc. The oldest executive at Aridis Pharmaceuticals Inc is Dr. Eric J. Patzer, 71, who is the Exec. Chairman.
Vu's mailing address filed with the SEC is C/O ARIDIS PHARMACEUTICALS, INC., 983 UNIVERSITY AVE, BLDG. B, LOS GATOS,, CA, 95032.
Over the last 6 years, insiders at Aridis Pharmaceuticals Inc have traded over $0 worth of Aridis Pharmaceuticals Inc stock and bought 1,445,847 units worth $181,502 . The most active insiders traders include Vu Truong, Eric Patzer и Fred Kurland. On average, Aridis Pharmaceuticals Inc executives and independent directors trade stock every 89 days with the average trade being worth of $125. The most recent stock trade was executed by Eric Patzer on 24 June 2024, trading 714,286 units of ARDS stock currently worth $50,000.
aridis is a privately held infectious diseases focused company in san jose, ca, usa. aridis’ advanced formulation and delivery technologies are combined with proprietary products portfolio to create potent drug candidates that are packaged into convenient to administer, "ready-to-use" formats.
Aridis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: